Does cyclosporin A worsen liver function in patients with inflammatory bowel disease and total parenteral nutrition?;¿La Ciclosporina A empeora la función hepática de pacientes con enfermedad inflamatoria intestinal y nutrición parenteral total?

Revista Espanola de Enfermedades Digestivas

Volumn 92, Issue 2, 2000, Pages 68-72

  Chicharro Serrano, Ma Luisa ^a   Guarner, L ^a   Vilaseca, J ^a   Planas, M ^a   Malagelada, J R ^a  

^a HOSPITAL UNIVERSITARI VALL D HEBRON   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN A; IMMUNOSUPPRESSIVE AGENT; METHYLPREDNISOLONE;

ARTICLE; CLINICAL ARTICLE; DISEASE ASSOCIATION; ENTERITIS; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LIVER DYSFUNCTION; LIVER FUNCTION TEST; LIVER TOXICITY; MALE; PARENTERAL NUTRITION; RISK FACTOR; TOTAL PARENTERAL NUTRITION;

ADULT; CYCLOSPORINE; FEMALE; HUMANS; IMMUNOSUPPRESSIVE AGENTS; INFLAMMATORY BOWEL DISEASES; LIVER DISEASES; LIVER FUNCTION TESTS; MALE; PARENTERAL NUTRITION, TOTAL; RETROSPECTIVE STUDIES;

EID: 0034093408     PISSN: 11300108     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Abad-Lacruz A, González-Huix F, Esteve M, Fernández-Bañares F, Cabre E, Boix J, et al. Liver function tests abnormalities in patients with inflammatory bowel disease receiving artificial nutrition: A prospective randomized study of total enteral nutrition vs total parenteral nutrition. JPEN 1990;14:618-21.
2. Baker AL, Rosenberg IH. Hepatic complications of total parenteral nutrition. Am J Med 1987;82:489-97.
3. Broomé U, Glaumann H, Hulterantz R. Liver histology and follow up of 68 patients with ulcerative colitis and normal liver function test. Gut 1990;31:468-72.
4. Feutren G. Clinical experience with sandimmune (cyclosporine) in autoinmune diseases. Transplant Proc 1992;24 (Supl 2):55-60.
5. Sandborn WJ. A critical review of cyclosporine therapy in inflammatory bowel disease. Inflamm Bowel Dis 1995;1: 43-63.
6. Santos JV, Baudet S, Casellas F, Guarner LA, Vilaseca JM, Malagelada JR. Intravenous cyclosporine for steroid refractory attacks of Crohn's disease. J Clin Gastroenterol 1995; 20:207-10.
7. Santos JV, Baudet S, Casellas F, Guarner LA, Vilaseca JM, Malagelada JR. Efficacy of intravenous cyclosporine for steroid. Refractory attacks of ulcerative colitis. J Clin Gastroenterol 1995;20:285-9.
8. Lichtiger S, Present HD, Kornbluth A, Gelernt I, Bauer J, Galler G. Cyclosporine in severe ulcerative colitis refractory to steroid therapy. N Engl J Med 1994;330:1841-5.
9. Moreno F, Morales JM, Colina F, Prieto C, Andrés A, Alcázar JM. Influence of long-term cyclosporine therapy on chronic liver disease after renal transplantation. Transplant Proc 1990;22:2314-6.
10. Truelove SC, Witts LJ. Cortisone in ulcerative colitis: Final report on a therapeutic trial. Br Med J 1955;2:1041-8.
11. Best WR, Beckektel JM, Singleton JW, Kern F. Development of a Crohn's disease activity index (CDAI). National Cooperative Crohn's Disease Study. Gastroenterology 1976;70:439-44.
12. Grant JP. Nutritional assessment in clinical practice. Nutr Clin Prac 1986;1:3.
13. Waterlow JC. Classification and definition of protein-calorie malnutrition. Br Med J 1972;3:566.
14. Oates JA, Wood AJJ. Cyclosporine. N Engl J Med 1989; 321:1725-38.
15. Kadmon M, Klünemann C, Böhme M, Ishikawa T, Gorgas K, Otto G. Inhibition by cyclosporin A of adenosine triphosphate-dependent transport from the hepatocyte into bile. Gastroenterology 1993;104:1507-14.
16. Kassianides C, Nussenblatt R, Palestine A, Mellow SD, Hoofnagle JH. Liver injury from cyclosporine A. Dig Dis Sci 1990;35:693-7.
17. Kuntmalm G, Säwe J. High dose methylprednisolone increases plama cyclosporin levels in renal transplant recipients. Lancet 1984;1:731.
18. Ost L. Effects of cyclosporin on prednisolone metabolism. Lancet 1984;1:451.
19. Actis GC, Denernardi-Venon W, Lagget M, Mazzano A, Ottobrelli A, Ponzetto A. Hepatoxicity of intravenous cyclosporin A in patients with ulcerative colitis on total parenteral nutrition. Liver 1995:320-3.